Lilly Delivers Strong Third-Quart...(55.7 12% 2533.1 2271.3 12% ...),Health

Marketing and

administrative 1,477.8 1,198.2 23% 4,339.3 3,579.0 21%

Acquired in-process

research and

development - - NM 656.6 - NM

Asset impairments,

restructuring and

other special

charges 81.3 - NM 204.3 - NM

------ ------ ------ ------

Operating income 1,128.6 1,049.8 8% 2,734.6 3,067.9 (11%)

Net interest

income(expense) (6.2) 4.8 (10.9) 2.1

Joint-venture

income - 23.8 11.0 66.1

Net other income 56.0 27.4 89.8 66.9

---- ---- ---- ----

Other income 49.8 56.0 89.9 135.1

Income before

income taxes 1,178.4 1,105.8 7% 2,824.5 3,203.0 (12%)

Income taxes 252.1 232.2 9% 725.9 672.6 8%

------- ------- ------- -------

Net income $ 926.3 $ 873.6 6% $2,098.6 $2,530.4 (17%)

------- ------- ------- -------

Earnings per share -

basic $ 0.85 $ 0.80 6% $ 1.93 $ 2.33 (17%)

------ ------ ------ ------

Earnings per share -

diluted $ 0.85 $ 0.80 6% $ 1.93 $ 2.33 (17%)

------ ------ ------ ------

Dividends paid per

share $ .425 $ 0.40 6% $ 1.275 $ 1.20 6%

Weighted-average

shares outstanding

(thousands) -

basic 1,090,067 1,085,603 1,089,809 1,085,441

'/>"/>